Adjuvant Chemotherapy in Patients With Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy

South Africa News News

Adjuvant Chemotherapy in Patients With Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy
South Africa Latest News,South Africa Headlines
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

Largest study of its kind reveals adjuvantchemotherapy improves overall survival for pancreaticcancer patients CUAnschutz JAMAOnc

Is there a survival benefit of adjuvant chemotherapy in patients with pancreatic adenocarcinoma after multiagent neoadjuvant chemotherapy?In this cohort study of 888 propensity score–matched patients who received multiagent neoadjuvant therapy, patients who received adjuvant chemotherapy survived significantly longer than patients who did not receive adjuvant chemotherapy . The benefit varied by age, pathological T category, and tumor differentiation.

Patients were excluded if they had clinical or pathological stage IV disease or died within 90 days of their operation.All included patients received NAC and underwent resection for primary PDAC. Some patients received adjuvant chemotherapy.The main outcome was the OS of patients who received AC vs those who did not . Interactions between pathological findings and AC were investigated in separate multivariable Cox regression models.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

A plea for personalization of the hemodynamic management of septic shock - Critical CareA plea for personalization of the hemodynamic management of septic shock - Critical CareAlthough guidelines provide excellent expert guidance for managing patients with septic shock, they leave room for personalization according to patients’ condition. Hemodynamic monitoring depends on the evolution phase: salvage, optimization, stabilization, and de-escalation. Initially during the salvage phase, monitoring to identify shock etiology and severity should include arterial pressure and lactate measurements together with clinical examination, particularly skin mottling and capillary refill time. Low diastolic blood pressure may trigger vasopressor initiation. At this stage, echocardiography may be useful to identify significant cardiac dysfunction. During the optimization phase, echocardiographic monitoring should be pursued and completed by the assessment of tissue perfusion through central or mixed-venous oxygen saturation, lactate, and carbon dioxide veno-arterial gradient. Transpulmonary thermodilution and the pulmonary artery catheter should be considered in the most severe patients. Fluid therapy also depends on shock phases. While administered liberally during the resuscitation phase, fluid responsiveness should be assessed during the optimization phase. During stabilization, fluid infusion should be minimized. In the de-escalation phase, safe fluid withdrawal could be achieved by ensuring tissue perfusion is preserved. Norepinephrine is recommended as first-line vasopressor therapy, while vasopressin may be preferred in some patients. Essential questions remain regarding optimal vasopressor selection, combination therapy, and the most effective and safest escalation. Serum renin and the angiotensin I/II ratio may identify patients who benefit most from angiotensin II. The optimal therapeutic strategy for shock requiring high-dose vasopressors is scant. In all cases, vasopressor therapy should be individualized, based on clinical evaluation and blood flow measurements to avoid excessive vasoconstriction. Inotropes should be considered in patients w
Read more »

Innovative precision oncology enabled by micro-organospheres derived from patientsInnovative precision oncology enabled by micro-organospheres derived from patientsInnovative precision oncology enabled by micro-organospheres derived from patients 3DCulture CellCulture Oncology TissueCulture precisiononcology microfluidics tumorsphere CellStemCell
Read more »

What is the prevalence of pulmonary tissue injury among hospitalized COVID-19 patients?What is the prevalence of pulmonary tissue injury among hospitalized COVID-19 patients?Researchers identified risk factors for and the prevalence of persistent pulmonary tissue alterations among hospitalized coronavirus disease 2019 (COVID-19) patients.
Read more »

Medicare Advantage vs Traditional Medicare and 30-Day Mortality Among Patients With Acute MIThis retrospective cohort study compares 30-day mortality rates between patients with acute myocardial infarction who are insured by Medicare Advantage vs traditional Medicare.
Read more »

Chronic UTI patients say antibiotic shortages are 'huge worry' after increase in Strep A casesChronic UTI patients say antibiotic shortages are 'huge worry' after increase in Strep A casesUnwell children have also been struggling to get hold of antibiotics in recent days, with one grandmother saying it is 'astonishing' that the UK is short of amoxicillin, a common type of penicillin
Read more »



Render Time: 2025-03-03 00:39:41